Skip to main content
logo
Targeted Medical Pharma, Inc. (TRGM)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Nov 12, 2025

Targeted Medical Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2015FY 2014FY 2013FY 2012FY 2011
Period Ending
Dec '15 Dec '14 Dec '13 Dec '12 Dec '11
Revenue
5.267.119.567.38.81
Revenue Growth (YoY)
-26.03%-25.57%30.96%-17.18%15.57%
Cost of Revenue
2.12.222.993.22.76
Gross Profit
3.174.96.574.16.05
Selling, General & Admin
5.047.359.7710.111.44
Research & Development
0.010.160.230.130.16
Operating Expenses
5.067.511010.2311.6
Operating Income
-1.89-2.61-3.43-6.14-5.55
Interest Expense
-1.17-1.23-0.56-2.26-0.88
Interest & Investment Income
--0.570.060.01
Other Non Operating Income (Expenses)
0.140.010.16--
EBT Excluding Unusual Items
-2.93-3.83-3.26-8.34-6.42
Merger & Restructuring Charges
-----0.23
Other Unusual Items
-0.14--0.41-4.43-
Pretax Income
-3.07-3.83-3.67-12.77-6.65
Income Tax Expense
-0.075.67-3.19-2.47
Earnings From Continuing Operations
-3.07-3.9-9.34-9.59-4.18
Minority Interest in Earnings
0.02----
Net Income
-3.04-3.9-9.34-9.59-4.18
Net Income to Common
-3.04-3.9-9.34-9.59-4.18
Shares Outstanding (Basic)
2726242222
Shares Outstanding (Diluted)
2726242222
Shares Change (YoY)
3.16%10.73%7.56%0.93%18.69%
EPS (Basic)
-0.11-0.15-0.39-0.43-0.19
EPS (Diluted)
-0.11-0.15-0.39-0.43-0.19
Free Cash Flow
-1.280.78-2.08-2.49-2.67
Free Cash Flow Per Share
-0.050.03-0.09-0.11-0.12
Gross Margin
60.16%68.84%68.72%56.12%68.70%
Operating Margin
-35.93%-36.71%-35.94%-84.15%-63.00%
Profit Margin
-57.86%-54.76%-97.72%-131.38%-47.41%
Free Cash Flow Margin
-24.30%10.97%-21.82%-34.11%-30.28%
EBITDA
-1.66-2.21-3.02-5.7-5.09
EBITDA Margin
-31.55%-31.06%-31.63%-78.18%-57.80%
D&A For EBITDA
0.230.40.410.440.46
EBIT
-1.89-2.61-3.43-6.14-5.55
EBIT Margin
-35.93%-36.71%-35.94%-84.15%-63.00%
Revenue as Reported
5.267.119.567.38.81
Source: S&P Global Market Intelligence. Standard template. Financial Sources.